TY  - JOUR
AU  - Harris, P N A
AU  - McNamara, J F
AU  - Lye, D C
AU  - Davis, J S
AU  - Bernard, L
AU  - Cheng, A C
AU  - Doi, Y
AU  - Fowler, V G
AU  - Kaye, K S
AU  - Leibovici, L
AU  - Lipman, J
AU  - Llewelyn, M J
AU  - Munoz-Price, S
AU  - Paul, M
AU  - Peleg, A Y
AU  - Rodríguez-Baño, J
AU  - Rogers, B A
AU  - Seifert, H
AU  - Thamlikitkul, V
AU  - Thwaites, G
AU  - Tong, S Y C
AU  - Turnidge, J
AU  - Utili, R
AU  - Webb, S A R
AU  - Paterson, D L
PY  - 2016
DO  - 10.1016/j.cmi.2016.10.023
UR  - http://hdl.handle.net/10668/10576
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI). Prospective studies, randomized trials or registered protocols comparing antibiotic therapies for BSI, published from 2005...
LA  - en
KW  - Antibiotic therapy
KW  - Bacteraemia
KW  - Bacterial infections
KW  - Clinical trials
KW  - Treatment outcome
KW  - Adult
KW  - Anti-Bacterial Agents
KW  - Bacteremia
KW  - Clinical Trials as Topic
KW  - Comparative Effectiveness Research
KW  - Endpoint Determination
KW  - Gram-Negative Bacterial Infections
KW  - Humans
KW  - Staphylococcal Infections
KW  - Treatment Outcome
TI  - Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.
TY  - research article
VL  - 23
ER  -